These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17404043)

  • 1. Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients.
    Rezaie A; Khalaj S; Shabihkhani M; Nikfar S; Zamani MJ; Mohammadirad A; Daryani NE; Abdollahi M
    Ann N Y Acad Sci; 2007 Jan; 1095():305-14. PubMed ID: 17404043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta 1 in relation to disease activity in Crohn's disease patients.
    Rezaie A; Ghorbani F; Eshghtork A; Zamani MJ; Dehghan G; Taghavi B; Nikfar S; Mohammadirad A; Daryani NE; Abdollahi M
    Ann N Y Acad Sci; 2006 Dec; 1091():110-22. PubMed ID: 17341608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis.
    Stadnicki A; Machnik G; Klimacka-Nawrot E; Wolanska-Karut A; Labuzek K
    Int Immunopharmacol; 2009 Jun; 9(6):761-6. PubMed ID: 19285572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1.
    Wiercińska-Drapało A; Flisiak R; Prokopowicz D
    Cytokine; 2001 Jun; 14(6):343-6. PubMed ID: 11497495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of VEGF and TGF-β1 during exclusive enteral nutrition in IBD.
    Wedrychowicz A; Kowalska-Duplaga K; Jedynak-Wasowicz U; Pieczarkowski S; Sladek M; Tomasik P; Fyderek K
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):150-5. PubMed ID: 21788755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of oxidative stress status and concentration of TGF-beta 1 in the blood and saliva of osteoporotic subjects.
    Yousefzadeh G; Larijani B; Mohammadirad A; Heshmat R; Dehghan G; Rahimi R; Abdollahi M
    Ann N Y Acad Sci; 2006 Dec; 1091():142-50. PubMed ID: 17341610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interactions between mucosal IL-1, IL-ra and TGF-beta 1 in ulcerative colitis.
    Ashwood P; Harvey R; Verjee T; Wolstencroft R; Thompson RP; Powell JJ
    Inflamm Res; 2004 Feb; 53(2):53-9. PubMed ID: 15021969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of enteral nutrition therapy on serum angiogenic growth factors concentrations in children].
    Wedrychowicz A; Kowalska-Duplaga K; Pieczarkowski S; Tomasik P; Spodaryk M; Fyderek K
    Przegl Lek; 2010; 67(1):31-5. PubMed ID: 20509569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
    Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
    Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.
    Moayyeri A; Daryani NE; Bahrami H; Haghpanah B; Nayyer-Habibi A; Sadatsafavi M
    J Gastroenterol Hepatol; 2005 Mar; 20(3):366-70. PubMed ID: 15740478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gingival crevicular fluid transforming growth factor-beta1 in cyclosporine and tacrolimus treated renal transplant patients without gingival overgrowth.
    Gürkan A; Afacan B; Emingil G; Töz H; Başkesen A; Atilla G
    Arch Oral Biol; 2008 Aug; 53(8):723-8. PubMed ID: 18342291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression with TGFbeta1 in the patients with ulcerative colitis].
    Wang YF; Wei B; Ouyang Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):204-6. PubMed ID: 15807267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in pulmonary function in patients with ulcerative colitis.
    Mohamed-Hussein AA; Mohamed NA; Ibrahim ME
    Respir Med; 2007 May; 101(5):977-82. PubMed ID: 17049827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.
    Yüksel O; Helvaci K; Başar O; Köklü S; Caner S; Helvaci N; Abayli E; Altiparmak E
    Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the levels of interferon-gamma and transforming growth factor-beta influence bronchial stenosis during the treatment of endobronchial tuberculosis.
    Kim Y; Kim K; Joe J; Park H; Lee M; Kim Y; Choi Y; Park S
    Respiration; 2007; 74(2):202-7. PubMed ID: 17124378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva Interleukin-6 in patients with inflammatory bowel disease.
    Aleksandra Nielsen A; Nederby Nielsen J; Schmedes A; Brandslund I; Hey H
    Scand J Gastroenterol; 2005 Dec; 40(12):1444-8. PubMed ID: 16316893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study of bronchial asthma associated with ulcerative colitis: role of airway microvascular permeability.
    Kanazawa H; Yoshikawa J
    Clin Exp Allergy; 2005 Nov; 35(11):1432-6. PubMed ID: 16297138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
    Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N
    Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.